Beijing Qiannianzhisheng Musical Instruments Co., Ltd. – Trademark Portfolio

Entity Type: 99

Beijing Qiannianzhisheng Musical Instruments Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 15 (Musical Instruments) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include QNZS. The owner is based in Beijing.

Room 504, 5th Floor, Building 2, No. 9 Huatuo Road, Daxing District,

Beijing 100000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

QNZS
QNZS
Registered 2025

Trademark Classifications

Beijing Qiannianzhisheng Musical Instruments Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

15
Musical Instruments (1 filing)

Musical instruments

Frequently Asked Questions

How many trademarks does Beijing Qiannianzhisheng Musical Instruments Co., Ltd. have?

Beijing Qiannianzhisheng Musical Instruments Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Beijing Qiannianzhisheng Musical Instruments Co., Ltd. file in?

Beijing Qiannianzhisheng Musical Instruments Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 15 (Musical Instruments). Class 15 covers musical instruments.

What are Beijing Qiannianzhisheng Musical Instruments Co., Ltd.'s most well-known trademarks?

Beijing Qiannianzhisheng Musical Instruments Co., Ltd.'s registered trademark portfolio includes well-known marks such as QNZS. These are among 1 currently registered trademark in the portfolio.

What is Beijing Qiannianzhisheng Musical Instruments Co., Ltd.'s trademark registration success rate?

Beijing Qiannianzhisheng Musical Instruments Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.